Paraganglioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials

Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease
Conditions:   Acyanotic Congenital Heart Disease;   Cyanotic Congenital Heart Disease;   Pheochromocytoma;   Paraganglioma Intervention:   Sponsors:   University Medical Centre Ljubljana;   University of Ljubljana, Faculty of Medicine;   University Rehabilitation Institute, Republic of Slovenia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2021 Category: Research Source Type: clinical trials

The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma
Conditions:   Malignant Adrenal Gland Pheochromocytoma;   Malignant Paraganglioma;   Pheochromocytoma, Metastatic;   Paraganglioma, Malignant;   Paraganglioma, Extra-Adrenal Intervention:   Drug: anlotinib hydrochloride Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2021 Category: Research Source Type: clinical trials